Exhalon

Reinventing respiratory diagnostics through breath analysis

[360Dx @360DxNews]

CARB-X Awards $1M Seed Funding for Exhalon's Breath-Based Lower Respiratory Tract Infection Test https://t.co/wLfrn8IbjF

[CARB-X @CARB_X]

@CARB_X has awarded @ExhalonLabs US$1M in seed funding to evaluate whether exhaled breath can be used as a non-invasive sample type to aid in the rapid and accurate diagnosis of lower-respiratory tract infections (LRTIs).

🔗 Read here: https://t.co/sULVKPbISi

[Exhalon @ExhalonLabs]

𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰𝘀 𝗮𝘀 𝗮 𝗰𝗼𝗿𝗻𝗲𝗿𝘀𝘁𝗼𝗻𝗲 𝗼𝗳 𝘁𝗵𝗲 #AMR 𝗿𝗲𝘀𝗽𝗼𝗻𝘀𝗲  — non-invasive, rapid tools are vital to guide therapy and curb unnecessary antibiotic use.
#diagnostic #artificalintelligence #Innovation

https://t.co/PyD9Y8dzdt

[Exhalon @ExhalonLabs]

@ExhalonLabs was at the 1st Global AntiMicrobial Resistance Innovators Conference
#GAMRIC #AMR #diagnostics #ArtificialIntelligence https://t.co/PyD9Y8d1nV

[Exhalon @ExhalonLabs]

@ExhalonLabs à l'événement l'Art du Care, organisé par l'institut @onepoint le 14 octobre. Notre technologie qui s'appuie sur la spectrométrie de masse et de l'#IA pour un #diagnostic médical des patients, non-invasif et instantané et avec de l'#impact.
https://t.co/qhf1gdbgeV